drugset / Trial / NCT01652417

Treatment of Renal Sarcoidosis by Methylprednisolone Bolus

NCT01652417

RandomizedParallel-groupOpen-labelTreatment

Summary

Renal sarcoidosis treatment is based on steroids, but the dose and duration are unknown. Despite this treatment, most patients will have chronic kidney disease. From our previous studies, the investigators believe that high dose steroids by methylprednisolone bolus will improve patient outcome and renal function.

Timeline

Start
2012-10
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 15 mg/kg Intravenous

Indications